Navigation Links
Nanotech researchers' 2-step method shows promise in fighting pancreatic cancer
Date:11/15/2013

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new technique for fighting deadly and hard-to-treat pancreatic cancer that uses two different types of nanoparticles, the first type clearing a path into tumor cells for the second, which delivers chemotherapy drugs.

The research team, led by Dr. Andre Nel, a UCLA professor of nanomedicine and a member of the California NanoSystems Institute at UCLA, and Dr. Huan Meng, a UCLA adjunct assistant professor of nanomedicine, has shown that this new drug-delivery technique is effective in treating pancreatic cancer in a mouse model.

The results of the study are published online in the journal ACS Nano and will be featured in the November 2013 print issue.

Pancreatic ductal adenocarcinoma, or pancreatic cancer, is a deadly disease that is nearly impossible to detect until it is in the advanced stage. Treatment options are limited and have low success rates. The need for innovative and improved treatment of pancreatic cancer cannot be overstated, the researchers said, as a pancreatic cancer diagnosis has often been synonymous with a death sentence.

Pancreatic ductal adenocarcinoma tumors are made up of cancer cells that are surrounded by other structural elements called stroma. The stroma can be made of many substances, including connective tissue and pericyte cells, which block standard chemotherapy drugs in tumor blood vessels from efficiently reaching the cancer cells, reducing the effectiveness of treatment.

The dual-wave nanotherapy method employed by Nel and Meng uses two different kinds of nanoparticles injected intravenously in a rapid succession. The first wave of nanoparticles carries a substance that removes the pericytes' vascular gates, opening up access to the pancreatic cancer cells; the second wave carries the chemotherapy drug that kills the cancer cells.

Nel and Meng, along with colleagues Dr. Jeffrey Zink, a UCLA professor of chemistry and biochemistry, and Dr. Jeffrey Brinker, a University of New Mexico professor of chemical and nuclear engineering, sought to place chemotherapy drugs into nanoparticles that could more directly target pancreatic cancer cells, but they first needed to find a way to get those nanoparticles through the sites of vascular obstruction caused by pericytes, which restrict access to the cancer cells.

Through experimentation, they discovered they could interfere with a cellular signaling pathway the communication mechanism between cells that governs the pericytes' attraction to the tumor blood vessels. By creating nanoparticles that effectively bind a high load of the signaling pathway inhibitor, the researchers were able to develop a first wave of nanoparticles that would separate the pericytes from the endothelial cells on the blood vessel. This would open the vascular gate for the next wave of nanoparticles, which carry the chemotherapeutic agent to the cancer cells inside the tumor.

To test this nanotherapy, the researchers used immuno-compromised mice in which they grew human pancreatic tumors called xenografts under the skin. With the two-wave method, the xenograft tumors had a significantly higher rate of shrinkage than tumors exposed only to chemotherapy given as a free drug or carried in nanoparticles without first-wave treatment.

"This two-wave nanotherapy is an existing example of how we seek to improve the delivery of chemotherapy drugs to their intended targets using nanotechnology to provide an engineered approach," said Nel, chief of UCLA's division of nanomedicine. "It shows how the physical and chemical principles of nanotechnology can be integrated with the biological sciences to help cancer patients by increasing the effectiveness of chemotherapy while also reducing side effects and toxicity. This two-wave treatment approach can also address biological impediments in nanotherapies for other types of cancer."


'/>"/>

Contact: Shaun Mason
smason@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Source:Eurekalert

Related medicine news :

1. Giving transplanted cells a nanotech checkup
2. Furnace Accelerator Startup SiO2 Nanotech Develops Anti-Fogging Technology for Variety of Applications
3. Outlook with Ben Kingsley Exploring Role of Nanotechnology in Medicine for Upcoming Report
4. Nanotech system, cellular heating may improve treatment of ovarian cancer
5. CWRU researchers aim nanotechnology at micrometastases
6. NIH awards $20 million over 5 years to train next generation of global health researchers
7. Researchers develop a new cell and animal model of inflammatory breast cancer
8. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
9. Researchers Find Gene Mutations That May Be a Key to Autism
10. Researchers find evidence of banned antibiotics in poultry products
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/13/2019)... NEW YORK (PRWEB) , ... ... ... of 3D printing—including medical and dental implants, additive manufacturing (AM)-enabled tissue fabrication, ... Every day, physicians are using AM medical technologies to improve patient care. ...
(Date:6/12/2019)... Va. (PRWEB) , ... June 12, 2019 , ... ... Andrea Miller, a quality assurance expert with more than 25 years of experience ... MDD Compliance for all classes of medical devices, has joined NDA Partners as ...
(Date:6/12/2019)... ... June 12, 2019 , ... We are excited ... for UPMC Pinnacle, a top-rated healthcare system, providing cutting-edge fertility treatment to patients ... for many premier insurance plans because of our commitment to evidence-based medicine and ...
(Date:6/11/2019)... ... 11, 2019 , ... Homecare Homebase (HCHB), the nation’s leader ... Management (RCM) service at the company’s annual Users Conference this week in Dallas. ... Services Suite, a collection of technology-enabled services designed to alleviate the burden associated ...
(Date:6/6/2019)... ... June 05, 2019 , ... ... the call for speaker proposals for its fourth annual Accountable Care Symposium on ... , The annual symposium brings together hundreds of health care leaders and providers ...
Breaking Medicine News(10 mins):
(Date:6/13/2019)... ... ... RxNT announced today that it has been named by Software Advice ... a leader in healthcare technology solutions. This is the fourth time RxNT has received ... best software products from North American small businesses. RxNT won the FrontRunner mental health ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... of health to improve patient outcomes, recently announced the launch of its new ... and pharmacies to develop a customized, local network of community resources focused on ...
(Date:6/13/2019)... Pa. (PRWEB) , ... June 13, 2019 , ... ... organization in the northeastern United States, today announced the appointment of Frank Ingari ... directly to Chief Executive Officer Anthony Coletta, M.D., M.B.A. , With more ...
Breaking Medicine Technology: